A role for Runx2 in normal mammary gland and breast cancer bone metastasis

Journal of Cellular Biochemistry

Volumn 96, Issue 3, 2005, Pages 484-489

  Shore, Paul ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bone; Mammary gland; Metastasis; Runx2; Transcription

Indexed keywords

BETA CASEIN; BETA GALACTOSIDASE; TRANSCRIPTION FACTOR RUNX2;

BONE METASTASIS; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL FUNCTION; GENE EXPRESSION; GENE LOCUS; HUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; BONE NEOPLASMS; BREAST NEOPLASMS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MAMMARY GLANDS, ANIMAL;

EID: 27144434594     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20557     Document Type: Review

References (31)

1. Ala-aho R, Kahari VM. 2005. Collagenases in cancer. Biochimie 87:273-286.
2. Ball RK, Friis RR, Schoenenberger CA, Doppler W, Groner B. 1988. Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kDa protein in a cloned mouse mammary epithelial cell line. EMBO J 7:2089-2095.
3. Barnes GL, Javed A, Waller SM, Kamal MH, Hebert KE, Hassan MQ, Bellahcene A, Van Wijnen AJ, Young MF, Lian JB, Stein GS, Gerstenfeld LC. 2003. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 63: 2631-2637.
4. Barnes GL, Hebert KE, Kamal M, Javed A, Einhorn TA, Lian JB, Stein GS, Gerstenfeld LC. 2004. Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease. Cancer Res 64:4506-4513.
5. Campbell PM, Der CJ. 2004. Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol 14:105-114.
6. Coffman JA. 2003. Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell Biol Int 27:315-324.
7. Franceschi RT, Xiao G. 2003. Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446-454.
8. Groner B. 2002. Transcription factor regulation in mammary epithelial cells. Domest Anim Endocrinol 23:25-32.
9. Guise TA. 1997. Parathyroid hormone-related protein and bone metastases. Cancer 80(8 Suppl):1572-1580.
10. 2+-binding protein of bone matrix. Haemostasis 16:258-272.
11. Inman CK, Shore P. 2003. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J Biol Chem 278: 48684-48689.
12. Inman CK, Li N, Shore P. 2005. Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein. Mol Cell Biol 25:3182-3193.
13. Javed A, Barnes GL, Pratap J, Antkowiak T, Gerstenfeld LC, van Wijnen AJ, Stein JL, Lian JB, Stein GS. 2005. Impaired intranuclear trafficking of Runx2 (AML3/ CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc Natl Acad Sci USA 102: 1454-1459.
14. Jimenez MJ, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C. 1999. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19:4431-4442.
15. Karsenty G. 2000. Role of Cbfa1 in osteoblast differentiation and function. Semin Cell Dev Biol 11:343-346.
16. Kim S, Koga T, Isobe M, Kern BE, Yokochi T, Chin YE, Karsenty G, Taniguchi T, Takayanagi H. 2003. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 17:1979-1991.
17. Komori T. 2002. Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem 87:1-8.
18. Martin TJ, Gillespie MT. 2001. Receptor activator of nuclear factor kappa B ligand (RANKL): Another link between breast and bone. Trends Endocrinol Metab 12:2-4.
19. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779.
20. Ning YM, Robins DM. 1999. AML3/CBFalpha1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene. J Biol Chem 274: 30624-30630.
21. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
22. Otto F, Kanegane H, Mundlos S. 2002. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum Mutat 19:209-216.
23. Prefontaine GG, Walther R, Giffin W, Lemieux ME, Pope L, Hache RJ. 1999. Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter. J Biol Chem 274:26713-26719.
24. Saito H, Oka T. 1996. Hormonally regulated double- and single-stranded DNA-binding complexes involved in mouse beta-casein gene transcription. J Biol Chem 271:8911-8918.
25. Selvamurugan N, Partridge NC. 2000. Constitutive expression and regulation of collagenase-3 in human breast cancer cells. Mol Cell Biol Res Commun 3:218-223.
26. Selvamurugan N, Kwok S, Partridge NC. 2004. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. J Biol Chem 279:27764-27773.
27. Stein GS, Lian JB, van Wijnen AJ, Stein JL, Montecino M, Javed A, Zaidi SK, Young DW, Choi JY, Pockwinse SM. 2004. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23:4315-4329.
28. Vegarud GE, Langsrud T, Svenning C. 2000. Mineral-binding milk proteins and peptides; occurrence, biochemical and technological characteristics. Br J Nutr 84(Suppl 1):S91-S98.
29. Weber GF. 2001. The metastasis gene osteopontin: A candidate target for cancer therapy. Biochim Biophys Acta 1552:61-85.
30. Yin JJ, Pollock CB, Kelly K. 2005. Mechanisms of cancer metastasis to the bone. Cell Res 15:57-62.
31. Yoneda T, Hiraga T. 2005. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun 328:679-687.